EU Parliament Endorses New Pharma Legislation, Provides More Market Protection for Companies 3/20/2024

Cautiously Stepping Into the Future of AI by Stepping Back Into the Past at DIA’s MASC 3/20/2024

With the Salary Growth Rate Slowing, Should Biopharma Employees Look for New Jobs? 3/20/2024

A new cancer treatment that uses a person’s own immune cells has been approved by the U.S. Food and Drug Administration (FDA) for treating the most dangerous type of skin cancer. Now this form of cellular therapy (tumor-infiltrating lymphocyte - or TIL therapy) is showing promise in advanced lung cancers through clinical trials underway at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).

AstraZeneca Buys Fusion in Potential $2B Deal, Joins Radiopharma Buying Spree 3/19/2024

Bayer’s Veozah Rival Hits Goals in Long-Term Phase III Hot Flash Study 3/19/2024

Engrail Raises $157M in Oversubscribed Series B to Move Neuro Pipeline Forward 3/19/2024

Crinetics Bags Second Phase III Win for Acromegaly, Heads for NDA Submission 3/19/2024

Orchard Wins FDA Approval for First Gene Therapy for Rare Pediatric Disease 3/19/2024

Bluebird Extends Cash Runway with $175M Financing to Support Gene Therapy Launch 3/19/2024

Regeneron Wins Appeal in Eylea-Lucentis Antitrust Case Against Novartis 3/19/2024

Report: 2024 U.S. Life Sciences Salary Trends 3/19/2024

A new study has discovered that a type of bacteria commonly found in the body, which usually does not pose problems for healthy people, plays a significant role in causing stomach cancer, the fifth most common cancer in the world.

Streptococcus anginosus bacteria exist alongside other germs in the mouth, throat, intestines and vagina. Occasionally, they may cause mild infections like sore throats and skin infections.

AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need 3/18/2024

GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data 3/18/2024

J&J-Backed Contineum Unveils IPO Plans to Advance MS Pipeline 3/18/2024

Pfizer to Lower Its Stake in GSK Consumer Health Spinoff Haleon 3/18/2024

AstraZeneca Caps US Inhaler Out-of-Pocket Costs on Heels of Boehringer 3/18/2024

Madrigal’s Rezdiffra Energizes MASH Space, Sets Bar for Future Therapies 3/18/2024

FDA Action Alert: Orchard, ITF, Merck and More 3/18/2024